For patients living with multiple chronic health conditions, better support is essential for ensuring they can effectively manage their medications and improve their quality of life.
COLUMBUS, Ohio (PRWEB) December 21, 2022
Today, Redi.Health, provider of the leading health management technology that puts patient support in your pocket, is announcing five digital patient engagement trends for the year ahead.
“For patients living with multiple chronic health conditions, better support is essential for ensuring they can effectively manage their medications and improve their quality of life,” said Luke Buchanan, co-founder and CEO of Redi.Health. “The industry is approaching a tipping point for how new technologies can empower patients to take more control of their health by delivering access to more information - we believe 2023 will be a pivotal year for the adoption of these solutions.”
According to recent estimates, chronic diseases will affect an estimated 164 million Americans – nearly half (49 percent) of the population by 2025, so it’s critical that they take advantage of digital tools that are available to them.
The experts at Redi.Health say 2023 is a year focused on patient-centric technology, and that has an impact on everyone. The industry should be prepared to see the following:
1. Patient access to pharmaceutical manufacturers: With the increase in patients becoming more comfortable with digital health during the COVID-19 pandemic, patients now expect all aspects of their health support to mimic the same convenience and ease as they experienced with pre-pandemic care. In 2023, manufacturers must join the digital age and allow patients to connect with them directly for enhanced support and seamless care. By embracing the digital experience, manufacturers will ultimately have new opportunities to connect with patients with who they previously had little or no engagement with in the past. Studies show patients who are introduced to support via robust digital platforms are four times more likely to utilize the support services and remain on therapy significantly longer than those who do not utilize digital options.
2. Consolidation of patient support: In 2023, the industry will see a merging of support services through the following two patient demands:
- Consolidation of channels: This is perhaps the most immediate need to be addressed. A consolidation of channels means that the path (or paths) that a patient takes to access various health services should be accessible in a convenient manner and through one or two “digital front doors.” For example, if co-pay, nursing support, educational materials, and doctor discussion guides are shown together as a menu or checklist for a patient, the patient is more likely to take advantage of all the services, which drives up adherence. Second, if that support is also consolidated to be as “in workflow” as possible for the patient's journey/management routine, it further promotes the convenience, applicability, and action taken on services.
- Consolidation of assets offered: This is an acknowledgment of the consumer's desire for simplicity related to what is needed and helpful. While deprioritizing what's not working and prioritizing what is working is not a novel strategy, when services are properly consolidated, the data available to what is appealing and impacting adherence becomes remarkably actionable. Take the above example: co-pay, nursing support, educational materials, and doctor discussion guide - if presented together and promoted as a linear journey, our understanding of what is accessed first, accessed most often, and what impacts establishment and persistence most potently becomes more actionable than ever. Leading to the tried and true strategy of deprioritizing what's not working and prioritizing what is working is being confidently informed with truly usable data and insights.
3. Compliant data architecture: Demands from patients and providers in 2023 will require a new data architecture strategy to better support patients on complex therapies. As digital patient support grows as part of manufacturers’ core strategies for engagement, so does the need for platform architecture that is built for the unique restrictions encountered by manufacturers. Many of the current options in the market for digital PSP are compliant by nature but lack applicability to end users due to their required focus on a single medication. The result is minimal engagement and, subsequently, minimal impact on adherence. On the other hand, traditional consumer health platforms offer broad applicability to end users, which captures their attention long-term and drives high engagement levels. However, these platforms are not designed in a way that allows for strong navigation of pharma’s unique compliance requirements, ultimately leading to minimal capability offerings (to maintain compliance) for a single product with support, which minimizes value to patients. Platforms will very likely begin to structure data in siloed ways that are built specifically for pharma compliance requirements and opinions. With robust security infrastructure between the proper data points, broader capabilities are unlocked that minimize risks to the manufacturer but maximize benefits to patients.
4. Increased connectivity from pharma to patient, to provider/stakeholder interoperability: One of the most exciting trends to come is the desire from providers and patients for more real-time connectivity between patient, provider, and now pharma support. Whether it be available through support services or integrated updates and status from hub services, the interoperability will soon advance rapidly. This requires advanced connectivity into platforms that have the capabilities of integration into pharma services and provider workflows and additionally need a digital front door available to patients. Though this trend is early, it will grow rapidly as support services become increasingly digital and is a highly competitive advantage to those who implement it. In general, real-time access updates between stakeholders and patients are significantly impacted when a patient starts a drug therapy (37 percent less time) and their adherence (56 percent more likely to stay on the medication).
5. All-in-one digital health platforms: These trends for 2023 and beyond lead to increased demand and prevalence for “all-in-one” digital health platforms. It’s a great buzzword, but what does it really mean? While it sounds like it means “has everything, all the time,” the trend that we at Redi have seen from patients is they see “all in one” as more of a “has what I need when I need it.” So it comes down to increased demand for platforms that can more effectively get the right service to the right patient at the right time. The demand from patients for platforms that utilize patient-reported outcomes and behavior to better identify what support they need, even if the patient isn’t aware it exists, will become increasingly prevalent in the space. The key will be selecting platforms that are swift to implement and highly customizable to keep up with the rapidly changing patient demand.
Redi.Health was recently included in CB Insights' fourth annual Digital Health 150 — an annual ranking of the 150 most promising private companies transforming healthcare with digital technology. Winners were selected from a pool of over 13,000 companies.
For more information about Redi.Health’s groundbreaking approach, visit https://www.redi.health/.
Redi.Health empowers patients with chronic conditions to understand, manage and track their total health through digital support. Combining health management technology and pharmaceutical manufacturer support into one tool, Redi.Health provides a mobile platform that allows patients to manage everything from multiple medications and symptoms to diet and exercise. By delivering a pathway for pharmaceutical companies, providers, and patients to connect and engage, Redi.Health customizes the complete health journey to drive better health outcomes.